Renal Cancer Research Review, Issue 17

In this issue:

Lenvatinib + pembrolizumab for mRCC
Fumarate hydratase-deficient RCC
Improvements in mRCC treatments over 40 years
Systemic targeted therapy for recurrent RCC
UK renal oncological surgical practice 2008-17
Lenvatinib + everolimus for advanced non-clear cell RCC
Reduced renal function and renal cancer-specific mortality
Active surveillance for risk stratification of small renal masses
RCC in patients under 40 years
Lymph node dissection during radical nephrectomy

Please login below to download this issue (PDF)

Subscribe